INTRODUCTION
fragments were separated by centrifugation of the reaction mixtures at 200,000 x g for 30 min.
RESULTS AND DISCUSSION
To identify novel substrates for presenilin-dependent γ-secretase, we conducted proteome analysis by subcellular fractionation and 2D electrophoresis. To detect the accumulation of novel substrates for γ-secretase, we first treated 293 cells with a γ-secretase inhibitor, Compound E (25). In order to achieve the enrichment of target transmembrane proteins, we performed subcellular fractionation to isolate membrane proteins using the 293 cells grown in the presence or absence of Compound E (Fig. 1A ). Both heavy (P2) and light (P3) membrane fractions were extracted with carbonate (100 mM Na 2 CO 3 at pH11) to remove peripherally attached membrane proteins (Fig. 1A) . Under these conditions, Cterminal fragments of APP (C83/99), known γ-secretase substrates, substantially accumulated in all γ-secretase-treated samples (Fig. 1B) . The remaining integral membrane proteins (CP2 and CP3) were further analyzed by 2D electrophoresis (Fig. 1C ) (data not shown for CP2).
Less than 1% of total identified spots in 2D gels accumulated in substantially higher levels in γ-secretase-treated cells as compared to control cells.
Based on the molecular size of protein spots detected and selectively present in the inhibitor-treated cells, we selected several type-I membrane candidate substrates. The following criteria were used to select the candidate substrates for further verification and analyses: i) size of the predicted intracellular domain ii) phorbol ester-enhanced or metalloprotease-mediated ectodomain shedding; iii) presence of extracellular dimerization motif. One of these candidates was ErbB4, a type-I membrane receptor tyrosine kinase (26).
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ErbB4 was shown to undergo constitutive ectodomain shedding to produce membraneanchored C-terminal fragment (27, 28) This cleavage appears to be mediated by TACE or a related metalloprotease (27, 28) and is greatly potentiated by the PKC activator TPA (29), similar to what has been reported for APP (30, 31). The reported size (~80kDa) of metalloprotease-generated ErbB4 C-terminal fragment corresponded to one of the spots in the 2D gel from Compound E-treated samples (Fig. 1C) .
When we transiently expressed the constructs encoding full-length ErbB4 with Cterminal HA epitope tag (21), full-length ErbB4 (~180 kDa) was constitutively processed to generate ~80 kDa C-terminal fragment ( Fig. 2A) , which was tightly associated with the membrane (Jung, K.-M. and Kim, T.-W., unpublished data). To evaluate the involvement of γ-secretase in the ErbB4 proteolysis, we studied the effects of the deficiency in presenilindependent γ-secretase activity. For this purpose, the accumulation of the ~80 kDa membraneassociated ErbB4 C-terminal fragments (B4-CTF) was examined in the stable 293 transfectants harboring constructs encoding wild-type (dW) or loss-of-function (dAsp: D385A-PS1 and D366A-PS2) forms of PS1 and PS2 (14, 32) . Similar to what has previously been reported using the CHO cells which overexpress both human APP and D257A-PS1/D366A-PS2 (14, 32, 33) , dAsp 293 cells accumulated endogenous APP C-terminal fragments to a substantially higher level as compared to either parental 293 or double wildtype cells (dW), and full-length PS1 and PS2 failed to undergo endoproteolytic processing (Fig. 2B) . The accumulation of ErbB4 C-terminal fragments was dramatically elevated in dAsp cells while the levels of full-length form were virtually unaffected (Fig. 2B) . As for the case in APP, the enhanced accumulation of B4-CTF was likely due to the increased stability.
This may be attributed to the deficient γ-secretase activity rather than increased ectodomain To directly assess the intramembrane cleavage of ErbB4 without stimulation with ligand, we expressed constructs encoding the truncated ErbB4 lacking the majority of entire extracellular regions (Fig. 4A) . To trace the precursor and product upon cleavage, the truncated construct (∆E2) encoded a polypeptide containing an HA epitope tag located immediately after the signal peptide in addition to the C-terminal V5 and 6xHis tags ( (Fig. 3A) led to the release of V5-epitope-tagged B4-ICD into the soluble fraction (Fig. 4C) . The release of B4-ICD was increased in a time-dependent manner in dW cells, whereas inhibition was occurred both in the both membrane fractions from dAsp cells and dW cells incubated with Compound E (Fig. 4C) , indicating that presenilin-dependent γ-secretase cleavage is responsible for the release of B4-ICD. In our system, Notch intracellular domain (NICD) was also generated in a γ-secretase inhibitor-sensitive manner when the membrane fractions prepared from dW cells transfected with Notch-∆E construct (15; Fig. 4D ).
To gain insight into the biological functions of the B4-ICD produced by presenilindependent intramembrane cleavage, we then examine its subcellular localization. We determined the subcellular localization of B4-ICD by expressing either GFP alone or an Nterminal GFP-tagged version of ErbB4 containing the entire intracellular domain (GFP-B4ICD; Fig. 5 ). As shown in Fig. 5 , GFP was distributed both in the nucleus and in the cytoplasm. In contrast, the GFP-B4ICD was predominantly in the nucleus (Fig. 5) Western blot analyses using anti-ErbB4 (8% SDS-PAGE). µM Cpd. E). After the reaction, both supernatant (S100) and the pellet (P100) were analyzed by Western blot analyses using anti-V5 antibody.
FIG. 4. In vitro generation of the ErbB4 intracellular domain (B4-ICD).
(D) Membrane fractions prepared from cells transfected with Notch-∆E constructs were subjected to the in vitro NICD generation assay as described in (C). S100 fractions were analyzed by anti-myc antibody.
FIG. 5. Nuclear localization of the ErbB4 intracellular domain (B4-ICD).
Confocal microscopy was performed to demonstrate the co-localization of GFP-B4ICD (B4-ICD fused with N-terminal GFP) and the DAPI nuclear staining (bottom panel). GFP controls are shown in the top panel. 
